Columns The MS Wire - A Column by Ed Tobias These Bills Could Help You Save Money on Prescription Medications These Bills Could Help You Save Money on Prescription Medications by Ed Tobias | March 20, 2018 Share this article: Share article via email Copy article link As we all know, the cost of prescription medications can be outrageous. Disease-modifying therapies aside, even with insurance, the medications we get from a pharmacy can take quite a bite out of a budget. Though many people don’t know it, there are times when it can actually be cheaper to pay for a therapy out-of-pocket than to have your insurance pay for it. But it’s not always easy to compare prices. In fact, there are actually “gag clauses” in some of the agreements that pharmacies have with insurance companies and prescription benefit managers. These clauses prohibit pharmacists from proactively telling you about potential savings. On Capitol Hill, however, a bipartisan group of senators has introduced a pair of bills that would gag the gag clauses. Sen. Susan Collins, R-Maine, is one of three Republicans and two Democrats who are sponsoring the measures. (The co-sponsors are Sens. Claire McCaskill, D-Mo., Debbie Stabenow, D-Mich., John Barrasso, R-Wyo., and Bill Cassidy, R-La. In a news release, Collins pointed out that one customer who used his insurance paid $129 for a medication. If he’d paid for it out-of-pocket, however, it would have cost him only $18. “Your pharmacist should be able to tell you if there’s a cheaper way to get the prescription drugs you need,” Collins said. “It’s outrageous that current practice prevents that, and our bipartisan bill would change it.” A recent study that reviewed 9.5 million insurance claims found that 23 percent of prescriptions filled through insurance ended up costing customers more than if they had paid for the medicine out-of-pocket. The overpayments totaled $135 million for 2013, or an average of $10.51 per covered member. The Journal of the American Medical Association published the study. The Patient Right to Know Drug Prices Act and the Know the Lowest Price Act would prohibit health insurers and pharmacy benefit managers from using those pharmacy gag clauses. The first bill would prohibit an insurer or a pharmacy benefits manager from restricting a pharmacy’s ability to provide drug price comparisons to someone who is covered by an insurance plan. The Know the Lowest Price Act would provide this same protection for people covered by Medicare Advantage and Medicare Part D plans. This pair of bills is just beginning to make its way through the legislative process. Let’s keep an eye on them. These are two bills that we, as patients, can support no matter what our political party is. You’re invited to follow my personal blog at www.themswire.com. *** Note: Multiple Sclerosis News Today is strictly a news and information website about the disease. It does not provide medical advice, diagnosis, or treatment. This content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website. The opinions expressed in this column are not those of Multiple Sclerosis News Today or its parent company, BioNews Services, and are intended to spark discussion about issues pertaining to multiple sclerosis. Print This Page About the Author Ed Tobias People say to write what you know and Ed Tobias knows about MS. He's lived with the illness since 1980, when he was 32 years old. Ed's a retired, award-winning broadcast journalist and his column combines his four decades of MS experiences with news and comments about the latest in the MS community. In addition to writing his column, Ed is one of the patient moderators on the MS News Today Facebook, Twitter, and Instagram sites. He’s also the author of “The Multiple Sclerosis Toolbox: Hints and Tips for Living with M.S.” Ed and his wife split their time between the Washington, D.C. suburbs and Florida’s Gulf Coast, trying to follow the sun. Tags legislation Comments Leave a comment Fill in the required fields to post. Your email address will not be published. Your Name Your Email Your Comment Post Comment
April 24, 2024 News by Lindsey Shapiro, PhD Autoantibodies seen in blood years before MS diagnosis: Study
April 23, 2024 News by Margarida Maia, PhD AAN 2024: Subcutaneous Ocrevus led to nearly no relapses after year